Literature DB >> 28454420

Study of the expression and function of ACY1 in patients with colorectal cancer.

Bing Yu1,2, Xuezhong Liu3, Xiuzhen Cao2, Mingyue Zhang2, Hong Chang1.   

Abstract

Aminoacylase 1 (ACY1) is important for regulating the proliferation of numerous types of cancer. However, the expression and mechanisms underlying the function of ACY1 in colorectal cancer remain unclear. In order to investigate the expression and function of ACY1 in colorectal cancer, tumor tissue and blood samples were collected for analysis from 132 patients diagnosed with colorectal cancer. Reverse transcription-quantitative polymerase chain reaction analysis and western blotting identified significantly increased expression of ACY1 mRNA in colorectal tumor tissue (P<0.05 vs. adjacent normal tissue) and notably increased ACY1 protein levels. This ACY1 mRNA expression was found to be positively correlated with tumor stage. In addition, plasma ACY1 concentration was increased in patients with colorectal cancer compared with healthy controls. Furthermore, in vitro knockdown of ACY1 in human colorectal cancer HT-29 cells was shown to inhibit proliferation and increase apoptosis. This effect was found to be associated with the activation of ERK1 and TGF-β1 signaling. In conclusion, the results of the present study suggest that ACY1 promotes tumor progression, and thus may be a potential target for the diagnosis and treatment of colorectal cancer.

Entities:  

Keywords:  aminoacylase 1; clinical diagnosis; colorectal cancer; tumor proliferation

Year:  2017        PMID: 28454420      PMCID: PMC5403499          DOI: 10.3892/ol.2017.5702

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  31 in total

Review 1.  The RAS/RAF/MEK/ERK and the PI3K/AKT signalling pathways: role in cancer pathogenesis and implications for therapeutic approaches.

Authors:  Antonella De Luca; Monica R Maiello; Amelia D'Alessio; Maria Pergameno; Nicola Normanno
Journal:  Expert Opin Ther Targets       Date:  2012-03-23       Impact factor: 6.902

2.  Colorectal cancer statistics, 2014.

Authors:  Rebecca Siegel; Carol Desantis; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2014-03-17       Impact factor: 508.702

3.  Attenuated metabolism is a hallmark of obesity as revealed by comparative proteomic analysis of human omental adipose tissue.

Authors:  Rafael Pérez-Pérez; Eva García-Santos; Francisco J Ortega-Delgado; Juan A López; Emilio Camafeita; Wifredo Ricart; José-Manuel Fernández-Real; Belén Peral
Journal:  J Proteomics       Date:  2011-10-01       Impact factor: 4.044

4.  Pancreatic exocrine enzyme-producing cell differentiation via embryoid bodies from human embryonic stem cells.

Authors:  Sakiko Shirasawa; Susumu Yoshie; Fengming Yue; Hinako Ichikawa; Tadayuki Yokoyama; Mika Nagai; Daihachiro Tomotsune; Masao Hirayama; Katsunori Sasaki
Journal:  Biochem Biophys Res Commun       Date:  2011-06-13       Impact factor: 3.575

5.  PACα--an optogenetic tool for in vivo manipulation of cellular cAMP levels, neurotransmitter release, and behavior in Caenorhabditis elegans.

Authors:  Simone Weissenberger; Christian Schultheis; Jana Fiona Liewald; Karen Erbguth; Georg Nagel; Alexander Gottschalk
Journal:  J Neurochem       Date:  2011-01-20       Impact factor: 5.372

6.  Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status.

Authors:  Eric Van Cutsem; Claus-Henning Köhne; István Láng; Gunnar Folprecht; Marek P Nowacki; Stefano Cascinu; Igor Shchepotin; Joan Maurel; David Cunningham; Sabine Tejpar; Michael Schlichting; Angela Zubel; Ilhan Celik; Philippe Rougier; Fortunato Ciardiello
Journal:  J Clin Oncol       Date:  2011-04-18       Impact factor: 44.544

7.  HDAC6-mediated EGFR stabilization and activation restrict cell response to sorafenib in non-small cell lung cancer cells.

Authors:  Zhihao Wang; Pengchao Hu; Fang Tang; Conghua Xie
Journal:  Med Oncol       Date:  2016-04-18       Impact factor: 3.064

8.  A Chinese herbal formula, Yi-Qi-Fu-Sheng, inhibits migration/invasion of colorectal cancer by down-regulating MMP-2/9 via inhibiting the activation of ERK/MAPK signaling pathways.

Authors:  Wanli Deng; Hua Sui; Qiaolin Wang; Nana He; Chunyan Duan; Liang Han; Qi Li; Ming Lu; Shuqin Lv
Journal:  BMC Complement Altern Med       Date:  2013-03-18       Impact factor: 3.659

9.  Serum aminoacylase-1 is a novel biomarker with potential prognostic utility for long-term outcome in patients with delayed graft function following renal transplantation.

Authors:  Matthew P Welberry Smith; Alexandre Zougman; David A Cairns; Michelle Wilson; Tobias Wind; Steven L Wood; Douglas Thompson; Michael P Messenger; Andrew Mooney; Peter J Selby; Andrew J P Lewington; Rosamonde E Banks
Journal:  Kidney Int       Date:  2013-06-05       Impact factor: 10.612

10.  Diagnostic and prognostic significance of different mucin expression, preoperative CEA, and CA-125 in colorectal carcinoma: A clinicopathological study.

Authors:  Parul Jain; Santosh Kumar Mondal; Swapan Kumar Sinha; Mrityunjoy Mukhopadhyay; Indranil Chakraborty
Journal:  J Nat Sci Biol Med       Date:  2014-07
View more
  6 in total

1.  Aminoacylase-1 plays a key role in myocardial fibrosis and the therapeutic effects of 20(S)-ginsenoside Rg3 in mouse heart failure.

Authors:  Qiong Lai; Fu-Ming Liu; Wang-Lin Rao; Guang-Ying Yuan; Zhao-Yang Fan; Lu Zhang; Fei Fu; Jun-Ping Kou; Bo-Yang Yu; Fang Li
Journal:  Acta Pharmacol Sin       Date:  2021-12-16       Impact factor: 7.169

2.  Proteomic profiling reveals biomarkers and pathways in type 2 diabetes risk.

Authors:  Debby Ngo; Mark D Benson; Jonathan Z Long; Zsu-Zsu Chen; Ruiqi Wang; Anjali K Nath; Michelle J Keyes; Dongxiao Shen; Sumita Sinha; Eric Kuhn; Jordan E Morningstar; Xu Shi; Bennet D Peterson; Christopher Chan; Daniel H Katz; Usman A Tahir; Laurie A Farrell; Olle Melander; Jonathan D Mosley; Steven A Carr; Ramachandran S Vasan; Martin G Larson; J Gustav Smith; Thomas J Wang; Qiong Yang; Robert E Gerszten
Journal:  JCI Insight       Date:  2021-03-08

3.  MicroRNA-212-5p and its target PAFAH1B2 suppress vascular proliferation and contraction via the downregulation of RhoA.

Authors:  Gwi Ran Kim; Tingwei Zhao; Hae Jin Kee; Seung-Jung Kee; Myung Ho Jeong
Journal:  PLoS One       Date:  2021-03-24       Impact factor: 3.240

4.  ACY1 regulating PTEN/PI3K/AKT signaling in the promotion of non-small cell lung cancer progression.

Authors:  Hong Chen; Wei Wang; Caizhi Xiao; Dongqin Xia; Fangfei Li; Shaoyong Liu
Journal:  Ann Transl Med       Date:  2021-09

5.  Aminoacylase 1 (ACY-1) Mediates the Proliferation and Migration of Neuroblastoma Cells in Humans Through the ERK/Transforming Growth Factor β (TGF-β) Signaling Pathways.

Authors:  Zimin Chen; Jiahui Gao; Jun Sun; Zhouguang Wu; Bin Wang
Journal:  Med Sci Monit       Date:  2021-02-23

6.  Proteomic analysis identifies deregulated metabolic and oxidative-associated proteins in Italian intrahepatic cholangiocarcinoma patients.

Authors:  Giuliana Cavalloni; Caterina Peraldo-Neia; Annamaria Massa; Carlo Bergamini; Alessandro Trentini; Giovanni De Rosa; Lorenzo Daniele; Fabiola Ciccosanti; Carlo Cervellati; Francesco Leone; Massimo Aglietta
Journal:  BMC Cancer       Date:  2021-07-28       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.